What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study

J Weddell, SL Hider, CD Mallen, S Muller - Rheumatology International, 2022 - Springer
Polymyalgia rheumatica (PMR) is common. The mainstay of treatment, glucocorticoids, are
associated with significant adverse effects and many patients remain on high doses for a …

Examining management and research priorities in patients with polymyalgia rheumatica: a primary care questionnaire survey

C Morton, S Muller, M Bucknall, K Gilbert… - Clinical …, 2019 - Springer
Introduction/objectives Polymyalgia rheumatica (PMR) is a common inflammatory disorder
that is usually managed with oral glucocorticoids, which although effective can cause …

Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study

S Muller, SL Hider, B Singh Sokhal… - … Advances in Practice, 2022 - academic.oup.com
Objectives PMR is a common inflammatory condition in older adults, characterized by
bilateral hip and shoulder pain and stiffness. Reducing oral glucocorticoids, classically used …

OP13. EVALUATING OUTCOMES IN POLYMYALGIA RHEUMATICA: PATIENT-REPORTED, PHYSICIAN-REPORTED OR CLINICAL MEASURES?

A Hutchings, D Lamping, J Hollywood, B Dasgupta - Rheumatology, 2005 - elibrary.ru
Background: Outcomes in rheumatological diseases have been evaluated using clinical,
physician-reported and patient-reported measures. The few studies that have evaluated …

Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League …

C Dejaco, YP Singh, P Perel, A Hutchings… - Annals of the …, 2015 - ard.bmj.com
To summarise evidence on therapeutic interventions and prognostic factors in polymyalgia
rheumatica (PMR). A systematic literature review was conducted using Ovid Medline …

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative …

C Dejaco, YP Singh, P Perel, A Hutchings… - Annals of the …, 2015 - ard.bmj.com
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

Exploring the patient experience in polymyalgia rheumatica

GK Harris, JL Leung, RRC Buchanan - Clinical Rheumatology, 2023 - Springer
Despite being the most common inflammatory rheumatic disease in the elderly (Partington et
al., Ann Rheum Dis 77 (12): 1750-175,), few studies to date have examined the patient …

An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists

AO Donskov, SL Mackie, EM Hauge… - …, 2023 - academic.oup.com
Objectives To explore current management practices for PMR by general practitioners (GPs)
and rheumatologists including implications for clinical trial recruitment. Methods An English …

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR

SL Mackie, S Arat, J Da Silva, C Duarte… - The Journal of …, 2014 - jrheum.org
We worked toward developing a core outcome set for clinical research studies in
polymyalgia rheumatica (PMR) by conducting (1) patient consultations using modified …

Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the American College of Rheumatology RISE Registry

SE Sattui, F Xie, Z Wan, C Clinton… - Arthritis Care & …, 2024 - Wiley Online Library
Objective This study describes the demographics, comorbidities, and treatment patterns in a
national cohort of patients with polymyalgia rheumatica (PMR) who received care from …